Corona Remedies Share Price: Corona Remedies debuted on Dalal Street with a significant 38.42% premium, opening at Rs 1,470 on NSE and Rs 1,452 on BSE. The Rs 655 crore IPO, entirely an offer for sale, was oversubscribed 144.5 times, highlighting strong investor confidence in its business model and niche market leadership.Read More
Wakefit Innovations listed flat on Monday, debuting at Rs 195 on the NSE and slightly lower on the BSE, in line with muted grey market expectations. The Rs 1,289-crore IPO saw moderate demand, with investors cautious amid aggressive valuations and a limited profitability track record despite strong brand presence.Read More
Tata Steel shares: The company announced plans to boost domestic capacity by nearly 50%, including a 4.8-million-tonne addition, aimed at strengthening market leadership and securing long-term raw material supplies.Read More
Markets await a backlog of US economic data, including jobs and inflation reports, which could shape investor sentiment and Federal Reserve policy expectations as equities navigate year-end volatility after recent tech-led losses.Read More
Global markets face a crucial week as political negotiations in Europe, a wave of delayed US economic data and key central-bank meetings converge, shaping expectations for growth, inflation and monetary policy in the year ahead.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
